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http://www.biomedcentral.com/1471-2334/14/165RESEARCH ARTICLE Open AccessField evaluation of a new antibody-based
diagnostic for Schistosoma haematobium
and S. mansoni at the point-of-care in northeast
Zimbabwe
Norman Nausch1,5, Emily M Dawson2*, Nicholas Midzi3,6, Takafira Mduluza4, Francisca Mutapi1 and
Michael J Doenhoff2Abstract
Background: Rapid diagnostic tests (RDTs) for use at the point-of-care (POC) are likely to become increasingly
useful as large-scale control programmes for schistosomiasis get underway. Given the low sensitivity of the
reference standard egg count methods in detecting light infections, more sensitive tests will be required to monitor
efforts aimed at eliminating schistosomiasis as advocated by the World Health Assembly Resolution 65.21 passed in
2012.
Methods: A recently developed RDT incorporating Schistosoma mansoni cercarial transformation fluid (SmCTF) for
detection of anti-schistosome antibodies in human blood was here evaluated in children (mean age: 7.65 years; age
range: 1-12 years) carrying light S. mansoni and S. haematobium infections in a schistosome-endemic area of
Zimbabwe by comparison to standard parasitological techniques (i.e. the Kato-Katz faecal smear and urine filtration).
Enzyme-linked immunosorbent assays (ELISAs) incorporating S. haematobium antigen preparations were also
employed for additional comparison.
Results: The sensitivity of the SmCTF-RDT compared to standard parasitological methods was 100% while the
specificity was 39.5%. It was found that the sera from RDT “false-positive” children showed significantly higher
antibody titres in IgM-cercarial antigen preparation (CAP) and IgM-soluble egg antigen (SEA) ELISA assays than
children identified by parasitology as “true-negatives”.
Conclusions: Although further evaluations are necessary using more accurate reference standard tests, these results
indicate that the RDT could be a useful tool for the rapid prevalence-mapping of both S. mansoni and S.
haematobium in schistosome-endemic areas. It is affordable, user-friendly and allows for diagnosis of both
schistosome species at the POC.
Keywords: Schistosomiasis, Diagnosis, Antibody-detection, Point-of-care, Neglected tropical disease* Correspondence: plxed2@nottingham.ac.uk
2School of Life Sciences, University of Nottingham, University Park,
Nottingham NG7 2RD, UK
Full list of author information is available at the end of the article
© 2014 Nausch et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Nausch et al. BMC Infectious Diseases 2014, 14:165 Page 2 of 9
http://www.biomedcentral.com/1471-2334/14/165Background
Schistosomiasis is a chronic disease caused by infection
with parasitic worms of the genus Schistosoma. It is en-
demic in over 70 tropical and sub-tropical countries,
with over 200 million people infected and a further 600
million people thought to be at risk. 90% of the people
infected reside in Sub-Saharan Africa, where S. mansoni
and S. haematobium infections are prevalent [1].
After the London Declaration of 30th January 2012 mo-
mentum towards the control of neglected tropical diseases
(NTDs), including schistosomiasis, by 2020 increased
markedly [2-4]. Efforts to control morbidity of the disease
are being stepped up worldwide and elimination is now an
aim following the 2012 WHA Resolution 65.21 which ad-
vocates elimination of schistosomiasis in some countries
[4,5]. Preventive chemotherapy, or mass drug administra-
tion (MDA), using praziquantel is the mainstay of control.
Prior to implementation of MDA treatment strategies,
the prevalence of infection in a given area is estimated
using the Kato-Katz faecal smear for S. mansoni infec-
tions, and urine filtration, and/or questionnaires for vis-
ible haematuria for S. haematobium infections [6]. A
control strategy for each area can then be devised fol-
lowing the WHO Guidelines for schistosome control,
which stratify control measures based on infection
prevalence [6]. While these traditional parasitological
methods of diagnosis are often useful in areas of high
endemicity, they are less sensitive for diagnosis in people
carrying low infection levels [7-13]. In areas of low infec-
tion intensity, which will occur if MDA campaigns are
successful, more sensitive methods of diagnosis will be
needed to ensure implementation of the most appropri-
ate treatment strategy for the given population. This is
particularly important for monitoring infection levels
and thus part of WHA 65.21 calls for strengthened sur-
veillance, which will require diagnostic methods which
can detect low infections. Furthermore, the WHO has
recently recommended that preschool-aged children be
included in treatment programmes [14]. A significant
proportion of these children harbour light infections
[15,16], and are therefore more likely to be missed by
traditional parasitological methods.
Much effort has been expended in development of
more accurate methods for diagnosing schistosomiasis
and these include development of molecular methods
for detection of parasite specific DNA in urine [17,18].
Detection of Dra1 tandem repeats using PCR has been
shown to be a promising technique for the diagnosis of
urogenital schistosomiasis [13,18]. It may currently be
the most sensitive and specific method available for the
diagnosis of schistosomiasis in low-endemic areas. How-
ever, it is unlikely to become useful for mapping pur-
poses in the near future due to the costs and difficulties
associated with performing PCR in the field.Antibody-detection assays have the merit of high sensi-
tivity [7]. In areas of low infection intensity, sensitivity has
previously been shown to decline [19], but despite this
they remain one of the best available methods for diagno-
sis in these areas [20-22]. They are likely to become in-
creasingly useful in Africa as control programmes get
underway and infection intensities decline [7,9]. Such has
been the case in the People’s Republic of China since the
1980s [23,24]. Antibody-detection methods are often criti-
cised for their lack of specificity but the lack of an accurate
‘gold’ standard diagnostic test makes this parameter diffi-
cult to assess. Antibody-positive, egg-negative patients
may in fact have infections that are missed by insensitive
parasitological methods.
While sensitive and specific diagnostic tests based on
antibody-detection are available, those that also meet
other ASSURED criteria (Affordable, Sensitive, Specific,
User-friendly, Rapid, Equipment-free, Deliverable) are the
most likely to be useful in schistosome-endemic areas
of low-middle income countries [25]. Most antibody-
detection assays currently available are relatively expen-
sive, trained technicians are required to perform the tests,
electricity is often needed (e.g. for blood centrifugation)
and it can take many hours to obtain results. A test that is
affordable, rapid, easy-to-use and works on whole blood
will obviate the need for a laboratory or even electricity
and allow diagnosis at the point-of-care (POC). POC diag-
nosis is beneficial not only for individual patients but it
will also allow for more rapid mapping of disease preva-
lence [26] and the acceleration of schistosomiasis control
programmes, factors which are important in efforts to
meet the 2020 goals [27].
Commercially available POC tests for schistosomiasis
include reagent strips for detection of micro-haematuria
(e.g. HemastixW, Bayer; Combur 10 TestW strips, Roche;
Medi test combi 9, Macherey-Nagel) and the POC-
circulating cathodic antigen (CCA) test (Rapid Medical
Diagnostics, Pretoria, South Africa). These have been
shown to be useful for diagnosis of S. haematobium
[28-30] and S. mansoni infections [31-36] respectively.
Both tests have their advantages and disadvantages: while
haematuria reagent strips are very inexpensive at ~ US
$0.33/test [28], their sensitivity and specificity are not suf-
ficiently high to make the assay useful for accurate diagno-
sis at the level of the individual. Haematuria can also
occur for other reasons such as inflammation from bac-
terial cystitis, sexually-transmitted infections, genital
mutilation and menstruation [37]. The POC-CCA test is
sensitive for S. mansoni infections [30-35] but less so
for S. haematobium [38,39], and its widespread use may
be limited to some extent by its cost [20], currently
around US$1.75/test [31].
In a collaborative study between the University of
Nottingham (Nottingham, UK), BioGlab Ltd. (Nottingham,
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rapid diagnostic test (RDT) for POC diagnosis of schisto-
somiasis has been developed. The test employs S. mansoni
cercarial transformation fluid (SmCTF) for the detection of
anti-schistosome antibodies in human blood. This antigen
has been shown to perform equivalently to schistosome sol-
uble egg antigens (SEA) in enzyme-linked immunosorbent
assays (ELISA) [40-42]. The SEA-ELISA is regularly
employed in travellers’ medicine clinics, and has also been
shown to be useful in schistosome-endemic areas
[22,24,39,43,44]. The SmCTF-RDT is designed to detect
both anti-S. mansoni and anti-S. haematobium antibodies.
Once commercially available it is thought that the SmCTF-
RDT will cost approximately US$1/test [45]. A recent
evaluation of the RDT for diagnosis of schistosomiasis in
preschool-aged children in Cote d’Ivoire suggests that it is
at least as sensitive as two Kato-Katz slides for the diagnosis
of S. mansoni infections and one urine filtration for the
diagnosis of S. haematobium infections [45]. Another study
showed that the sensitivity of the test was however reduced
in children aged below three years on the shorelines of Lake
Albert, Uganda [46]. Here we further evaluated the diag-
nostic accuracy of the SmCTF-RDT by comparison to trad-
itional parasitological methods of diagnosis in children of
Murehwa, in Mashonaland East province, Zimbabwe, an
area co-endemic for both S. haematobium and S. mansoni
infections. ELISAs incorporating S. haematobium antigen
preparations were also performed to further strengthen the
results.
Methods
Ethical approval and consent
Institutional and ethical approval was received from the
University of Zimbabwe’s Ethical Review Board and the
Medical Research Council of Zimbabwe, respectively. In
addition permission to work in the indicated area was
given by the Provincial Medical Director, by the District
Educational Officer and Heads of Schools. Only compliant
participants were recruited and they were free to drop out
at any point during the study. At the beginning of the
study, participants and parents/guardians had the aims
and procedures of the project explained fully in the local
language, Shona, prior to obtaining consent and assent.
All subjects, or parents/guardians of minors, provided in-
formed written consent and assent before parasitology
and blood samples were obtained. After collection of all
samples, all participants were offered anti-helminthic
treatment with the recommended dose of praziquantel
(40 mg/kg of body weight) which was administered to all
compliant participants by the local physician.
Study population
This study was part of a larger on-going investigation into
the health benefits of repeated treatment of schistosomeinfections in preschool children. The study population
was chosen based on Ministry of health national survey
data obtained in 2010 and the study was performed in
February 2012 [47,48]. Data from the National survey
indicated that overall prevalence in selected schools
was >50% for S. haematobium and therefore classified as
having high endemicity based on WHO criteria [49]. Data
of the National survey also indicated a lower prevalence of
S. mansoni (<20%) and the absence of soil-transmitted
helminths (STHs). Testing for both S. mansoni and STHs
was done using both the Kato-Katz technique and formol-
ether concentration. Prevalence of S. haematobium in the
selected area was checked two weeks before the actual
survey by screening children in grade 7 (12-14 years of
age). The prevalence within grade 7 was >70% confirming
the high prevalence in this area. The study was perfor-
med in two villages, Chingwaru and Chingono (31°63’E;
17°52′S and 31°66′E; 17°55′S), Murehwa district, Mashonaland
East province in northeast Zimbabwe. The two villages
have insufficient safe water and sanitation facilities as
confirmed by questionnaire. The villagers are mainly
subsistence farmers and have frequent contact with
schistosome-infected water. Questionnaire studies showed
that infants and preschool children have passive water con-
tact mainly when they accompany older siblings/parents/
guardians to the water e.g. being washed in infested water
collected from rivers. Older children are exposed to infec-
tion while playing, bathing and performing domestic
chores. At the time of this study the area had not been in-
cluded in any schistosome control programmes and partici-
pants had not received any prior anti-helminthic treatment.
Inclusion criteria
To be included in the study participants had to meet fol-
lowing general criteria: 1) should not have received anti-
helminthic treatment prior to the study (both assessed
by questionnaires to the children or their parents/guard-
ians), 2) be healthy as assessed by a clinical examination
conducted by the local nurses. Children were excluded
from the final analysis if they had no egg count results
for both S. mansoni and S. haematobium, and also if an
egg count result was available for only one species and it
was negative, since in such instances the presence of the
other species could not be excluded. A total of 97 chil-
dren met these criteria and were included in the study.
91 children were included in the final analysis (see
STARD flowchart: Supplementary information).
Diagnostic methods
Parasitology
For the analysis of S. haematobium and S. mansoni
children submitted up to four urine and four stool sam-
ples (over four consecutive days). 10 ml of each urine
sample received was processed on the day of collection
Figure 1 Negative and positive results on the Schistosoma
mansoni cercarial transformation fluid rapid diagnostic test
(SmCTF-RDT). The negative test shows the presence of only one
band – the control, whereas the positive test shows the presence of
a second band. This band shows that there has been a reaction
between antibodies in the sample and SmCTF.
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and examined on the day of collection using the Kato-
Katz faecal smear for detection of S. mansoni eggs [51].
A single slide for microscopic examination was prepared
from each stool (41.7 mg) and urine sample.
Blood collection and analysis
Up to 10 ml of venous blood was collected from study
participants (depending on age) by trained nurses and
collected in silica-coated tubes (BD Biosciences) without
anticoagulant. Blood was stored overnight at 4°C and
sera separated by centrifugation at 1800 rpm for 10 min.
10 μl of serum was taken for testing on SmCTF-RDTs,
and the rest was initially frozen at -20°C and afterwards
stored at -80°C for testing in ELISA and other unrelated
studies. Samples were transported to Edinburgh frozen
at -80°C prior to immunological assays.
SmCTF-RDTs
SmCTF was produced by BioGlab Ltd. (Nottingham, UK)
according to a previously described method [40]. The
freeze-dried SmCTF was sent to Vision Biotech (Cape
Town, South Africa) for incorporation into the RDTs,
which are designed to detect IgG against the SmCTF.
Quality control procedures, which involved testing
SmCTF-RDTs with schistosome-positive reference sera
and European negative controls, were performed prior to
distribution of SmCTF-RDTs. In the field, tests were car-
ried out according to the manufacturer’s instructions;
briefly, 10 μl of serum was added to a test cassette,
followed by 2-3 drops of buffer (provided in the test pack).
After 15 min the results were recorded as either positive
or negative, depending on whether or not a coloured test
band had appeared on the cassette (Figure 1). Read-outs
from the test were clear, with positives and negatives easily
distinguishable. Readers of the test were blinded with re-
spect to the results of parasitological testing.
Serological antibody assays
Sera from the majority of the children included in this
study were analysed by ELISA using a S. haematobium
cercarial antigen preparation (CAP), soluble egg antigens
(SEA) and a soluble worm antigen preparation (SWAP). S.
haematobium antigen preparations were obtained from
the Theodor Bilharz Institute (Giza, Egypt). IgM responses
against CAP (n = 75) and SEA (n = 75) were recorded and
the SWAP-IgG was also measured (n = 77). Sufficient vol-
umes of serum for testing by ELISA were not available
from all children, as the amount of blood obtained from
young children was very limited in some cases.
ELISAs were performed as previously described [52].
Microtiter plates were coated overnight at 4°C with
5 μg/ml CAP or 5 μg/ml SWAP or with 10 μg/ml SEA,
all diluted in carbonate-bicarbonate buffer. Plates werewashed with PBS/0.03% Tween20 and blocked for two
hours using 5% skimmed milk in PBS/0.03% Tween20.
Plates with diluted serum samples (1:100) were incu-
bated for two hours at 37°C. Following three wash steps,
anti-human horseradish peroxide-conjugated polyclonal
antibodies against IgG and IgM (1:1000; antibodies sup-
plied by Dako, Glostrup, Denmark) were added and
incubated for one hour at 37°C. ELISA plates were
developed using 2,2’-azino-bis-(3-ethylbenzthiazoline-6-
sulfonic acid) solution (ABTS; Southern Biotech, Birmingham,
USA). Reactions were stopped after 15 min for SEA-
IgM and 10 min for CAP-IgM and SWAP-IgG using
25% hydrochloric acid. Absorbance was read at 405 nm
using an Emax precision microplate reader (Molecular
devices, Sunnyvale, USA).
Statistical analysis
The sensitivity and specificity of the RDT were calculated
using egg-detection as the reference standard for diagnosis
of schistosome infections. Specificity, i.e. the percentage of
negative individuals correctly identified as such, was calcu-
lated using the formula:
Specificity ¼ number of true negatives TNð Þ
= number of TNþ number of false positives FPð Þð Þ:
Sensitivity, i.e. the percentage of positive individuals cor-
rectly identified as such, was calculated using the formula:
Sensitivity ¼ number of true positives TPð Þ
= number of TPþ number of false negatives FNð Þð Þ:
Nausch et al. BMC Infectious Diseases 2014, 14:165 Page 5 of 9
http://www.biomedcentral.com/1471-2334/14/165Also calculated were the positive predictive value (PPV),
i.e. the proportion of positive test results that are truly
positive, and negative predictive value (NPV), i.e. the pro-
portion of negative test results that are truly negative.
These were calculated using the formulas:
PPV ¼ TP= TPþ FPð Þ
NPV ¼ TN= TNþ FNð Þ:
Statistical analyses were conducted using Stata version
12 (StataCorp. 2011. Stata Statistical Software: Release 12.
College Station, TX: StataCorp LP) and GraphPad Prism
version 5 (GraphPad Software, Inc., La Jolla, USA). Uni-
variate logistic regression analysis was used to determine
whether the number of samples of excreta (categorical, x)
submitted for analysis had an effect on the outcome of the
SmCTF-RDT result (binary, y). Due to small sample sizes,
differences in test performance (categorical data) between
age groups were analysed using Fisher’s exact test. Anti-
body data did not meet assumptions allowing for a para-
metric test. Thus, differences in antibody levels were
analysed using the non-parametric Kruskal-Wallis test
with multiple comparison by Dunn’s post-test. Statistical
significance was assigned at P < 0.05 for all analyses. The
P-value was two-tailed.
Results
The 91 children included in the final analyses submitted
varying numbers of urine and faecal samples over the
four days of sampling (see Additional file 1: STARD
flowchart in online supplementary information). Five
children were missing S. mansoni egg count data, but
were still included in the analysis since they were posi-
tive for S. haematobium eggs. The remaining children
submitted at least one urine sample and one faecal sam-
ple for analysis by filtration for S. haematobium eggs
and a Kato-Katz slide for S. mansoni eggs respectively.
The mean age was 7.65 years (range 1-12 years) and
there was a 1.4:1 male:female sex ratio. These and other
details of the study participants are shown in Table 1.
The available parasitological data confirmed that five
children were infected with S. mansoni only, five children
had both S. mansoni and S. haematobium infections, andTable 1 Description of the study population
Age
group
(years)
Sample
size (n)
Mean
age
(range)
Sex
M/F
S. ha
Mean egg
count ± SEM (ran
<6 18 4.24 (1-5) 10/8 6.26 ± 2.90 (0-4
6-12 73 8.49 (6-12) 43/30 24.23 ± 7.98 (0-53
Total 1-12 91 7.65 (1-12) 53/38 20.67 ± 6.46 (0-53
91 children from two villages Chingwaru and Chingono (31°63’E; 17°52′S and 31°66
northeast Zimbabwe.
SEM - Standard error of mean, CI - Confidence Interval.43 children were infected with S. haematobium only. 38
children were negative for eggs of both schistosome spe-
cies. The overall prevalence of schistosomiasis was 58.2%
(95% confidence interval (CI): 47.4-68.5) with S. mansoni
prevalence being 11.0% (95% CI: 5.4-19.3) and that of S.
haematobium being 52.8% (95% CI: 42.0-63.3). Of the S.
haematobium egg-positive cases, 38 children had light in-
fections (defined by the WHO as <50 eggs per 10 ml urine
[49]) and 10 children had heavy infections (defined by the
WHO as ≥50 eggs per 10 ml urine). The mean egg count
of S. haematobium egg-positive children was 39.2 eggs per
10 ml urine (standard error of the mean - SEM ± 11.67).
Of the 10 S. mansoni egg-positive cases there were two
children with moderate infection intensities (as defined by
the WHO as 100-399 eggs per gram (epg) [49]) while the
remaining 8 had light infections (as defined by the WHO
as 1-99 epg). The mean epg of egg-positives was 38.4
(SEM± 13.68).
The SmCTF-RDT estimated prevalence of anti-schistosome
antibodies to be 83.5% (95% CI: 74.5-89.9). The diagnos-
tic accuracy of the RDT compared to the egg-detection
methods used as a reference standard is shown in
Table 2. All 53 schistosome infections detected by para-
sitology were also detected by the SmCTF-RDT, and
therefore sensitivity was 100% (95% CI: 93.3-100). Of
the 38 children that were negative by parasitological
methods, only 15 were also negative by the SmCTF-
RDT, and therefore specificity was 39.5% (95% CI: 24.0-
56.6). The positive predictive value (PPV) and negative
predictive value (NPV) were 69.7% (95% CI: 58.1-79.8)
and 100% (95% CI: 78.2-100) respectively (Table 2).
There was no significant difference between the specifi-
city of the SmCTF-RDT in preschool-aged children
(<6 years of age) compared to school-aged children
(6-12 years of age) (60.0% and 36.4% respectively; P =
0.365) as determined by Fisher’s exact test. There was
also no significant difference between the PPV of the
SmCTF-RDT in preschool-aged children (<6 years of
age) compared to school-aged children (6-12 years of
age) (61.5% and 71.4% respectively, P = 0.813). Logistic
regression analysis showed there was no clear associ-
ation between the SmCTF-RDT results and the number
of urine and faecal samples submitted for examinationematobium S. mansoni
ge)
Prevalence
in % (CI)
Mean egg
count ± SEM (range)
Prevalence
in % (CI)
1) 38.9 (17.3-64.3) 0.03 ± 0.03 (0-0.5) 5.6 (0.1-27.3)
3.0) 56.2 (44.1-67.8) 0.23 ± 0.11 (0-5.5) 12.3 (5.8-22.1)
3.0) 52.8 (42.0-63.3) 0.19 ± 0.09 (0-5.5) 11.0 (5.4-19.3)
′E; 17°55′S), Murehwa district, Mashonaland East province in
Table 2 Diagnostic accuracy of the rapid antibody test for schistosomiasis compared to parasitological techniques as
the reference standard
SmCTF-RDT
result
Egg-positive
children (n = 53)
Egg-negative
children (n = 38)
Sensitivity
(95% CI)
Specificity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
Positive 53 23 100% (93.3-100) 39.5% (24.0-56.6) 69.7% (58.1-79.8) 100% (78.2-100)
Negative 0 15 - - - -
Accuracy of the Schistosoma mansoni cercarial transformation fluid rapid diagnostic test (SmCTF-RDT) for diagnosis of S. mansoni and S. haematobium infections
compared to standard parasitological methods (the Kato-Katz faecal smear and urine filtration respectively).
CI – Confidence Interval; PPV – Positive Predictive Value; NPV – Negative Predictive Value.
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those children who submitted less than two urine and
two faecal samples (n = 18) did not alter the outcome of
calculations of diagnostic accuracy.
For most of the 91 children enrolled in the study sera
were available which were further analysed using ELISA
with S. haematobium CAP, SEA and SWAP. The IgM
responses to CAP and SEA in ELISA are presented in
Figure 2A and 2B respectively, categorised according to
absence or presence of schistosome eggs and SmCTF-
RDT results. Both the mean anti-CAP and anti-SEA OD
readings of SmCTF-RDT negative results were signifi-
cantly lower than the mean OD readings of both
SmCTF-RDT “true-positives” and SmCTF-RDT “false-
positives” (Figure 2A and 2B). There was no significant
difference between the mean OD readings of SmCTF-
RDT “true-positives” and SmCTF-RDT “false-positives”
using either assay. The IgG response to SWAP across
the different parasitological findings and RDT results is
shown in Figure 2C. The mean anti-SWAP OD readings
of SmCTF-RDT negative results were significantly lower
than the mean OD readings of both SmCTF-RDT “true-
positives” and SmCTF-RDT “false-positives”. The meanFigure 2 Antibody isotype levels against different Schistosoma haema
children included in this study from Murehwa, Mashonaland East province, Zimba
against cercarial antigen preparation (CAP), B: IgM against soluble egg antigens (SE
immunosorbent assay (ELISA) optical density readings are classified according to S
results and infection status as determined by egg counts. (black circle) Egg-negativ
(inverted red triangle) S. mansoni and S. haematobium egg-positive, (red diamondOD for SmCTF-RDT “false-positives” was also however
significantly lower than that of the RDT-positive/S. hae-
matobium egg-positive patients.
Discussion
Before the onset of schistosomiasis control programmes
the prevalence of infection in a given area needs to be esti-
mated in order for implementation of an appropriate
MDA strategy. In order to achieve the WHO’s 2020 goals
and WHA Resolution 65.21, control efforts will need to be
scaled up and accelerated [27]. As we move towards elim-
ination, the prevalence and intensity of schistosome infec-
tions will decrease and it will therefore be increasingly
difficult to detect these infections using egg detection
methods. The need for a more rapid and accurate method
of diagnosis is therefore greater than ever.
This study employed a newly-developed RDT that em-
ploys SmCTF, an antigen preparation from S. mansoni
cercariae, for detection of anti-schistosome IgG anti-
bodies in human serum or whole blood (e.g. from a
finger-prick [45]). The rapidity with which the test yields
a result enables treatment to be administered almost
immediately.tobium antigen preparations. Specific antibody isotype levels of the
bwe, against different Schistosoma haematobium antigen preparations: A: IgM
A), C: IgG against soluble worm antigen preparation (SWAP). Enzyme-linked
. mansoni cercarial transformation fluid rapid diagnostic test (SmCTF-RDT)
e, (black square) Egg-negative, (red triangle) S. haematobium egg-positive,
) S. mansoni egg-positive. * P< 0.05, ** P<0.01, ***P<0.001.
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shown that the RDT is as sensitive as two Kato-Katz
slides and two POC-CCA tests for the diagnosis of S.
mansoni infections, and as sensitive as one urine filtra-
tion for the diagnosis of S. haematobium infections in
preschool-aged children of Côte d’Ivoire [45]. While the
SmCTF-RDT was highly sensitive for the diagnosis of S.
mansoni infections in 3-5 year olds of Lake Albert,
Uganda, sensitivity was reduced in children aged under
3 years [46]. Evaluation of the SmCTF-RDT has been ex-
tended here. The accuracy of the SmCTF-RDT for diag-
nosis of S. mansoni and S. haematobium infections was
assessed in young children (12 years and under) from
Murehwa, located in the Mashonaland East province of
Zimbabwe. Those children diagnosed as positive by
parasitology were mainly harbouring light infections.
The SmCTF-RDT was 100% sensitive compared to para-
sitological methods for the diagnosis of both schistosom-
iasis mansoni and haematobium. Specificity was 39.5%,
PPV was 69.7% and NPV was 100%, with no difference
found in the performance of the test between those chil-
dren of preschool-aged (<6 years) and those of school-
age (6-12 years). The high NPV observed here indicates
that the SmCTF-RDT is unlikely to miss any egg-
positive infections, and it could be therefore a useful tool
for screening purposes. The PPV indicates that 69.7% of
the SmCTF-RDT positive results will be “true”, i.e. egg-
positive, infections.
The low specificity of the RDT compared to egg-
detection methods is consistent with that reported previ-
ously [45,46]. Antibody-detection methods are known to
give much higher estimates of prevalence than parasito-
logical methods [11,39,53,54] and it has previously been
suggested that this may be a direct consequence of the
relative insensitivity of the latter [8,9]. In this study up
to four Kato-Katz slides and four urine filtrations were
performed per child and the prevalence of schistosome
infections was as expected from the data of the National
survey. It has however been shown previously that infec-
tions can still be missed after larger numbers of parasito-
logical examinations [11,55]. Here we therefore further
analysed serum samples collected using IgM-ELISA
against S. haematobium CAP and SEA, and IgG-ELISA
against S. haematobium SWAP. For the CAP-IgM and
SEA-IgM assays, there was no significant difference
found between the mean antibody titres of SmCTF-RDT
“true-positives” and “false-positives”. Importantly, there
was however a significant difference between the mean
ODs of SmCTF-RDT-negative/egg-negative children and
SmCTF-RDT positive children (irrespective of whether
or not eggs were found in excreta). This was not the case
with the IgG-ELISA; although there was a significant dif-
ference between the mean antibody titres of SmCTF-
RDT-negative/egg-negative children and SmCTF-RDTpositive children (irrespective of whether or not eggs were
found in excreta), there was also a significant difference
between the mean ODs of SmCTF-RDT “true-positives”
and “false-positives”. SEA and CAP have both previously
been shown to be more reactive against anti-schistosome
antisera in ELISA than SWAP [56,57]. In this study, the
results of the SWAP-IgG ELISA seem to be more compar-
able to egg counts, which has also been demonstrated
previously by Osada et al. [58]. The ability of the SmCTF-
RDT to detect antibodies as accurately as the ELISAs
incorporating SEA and CAP is a promising result. At the
pre-treatment stage, the apparent lack of specificity of
these tests could mainly be due to the relative insensitivity
of parasitological techniques. Anti-schistosome antibodies
that are detected by SmCTF are likely induced by immu-
nogens derived from eggs lodged in the tissues of infected
humans and it is therefore improbable that SmCTF de-
tects single-sex worm-alone infections [41]. Since schisto-
somes are long-lived and the studied population here was
very young, the likelihood of aborted infections is very
small.
Limitations of the study
Further evaluations are needed in areas where schistosom-
iasis is non-endemic to determine whether there is cross-
reactivity with antibodies against other infections. SmCTF
has previously been shown to exhibit some cross-
reactivity with sera from other infections in an ELISA
format [41], and this cross-reactivity may be responsible
to some degree for the apparent lack of specificity of the
SmCTF-RDT. Here the studied population was however
deemed to be uninfected with STHs based on data from
the National survey. More sensitive assays (such as
antibody-detection techniques) could be employed in
future studies to confirm this to be true.
The sample size used here was limited due to a lack of
resources and needs to be increased in future studies.
Evaluations into the test’s diagnostic accuracy should
now be extended using larger sample sizes, more diverse
age groups and in areas of lower endemicity. More ac-
curate reference standard tests, such as an increased
number of parasitological examinations and the Dra 1
PCR technique [18], should also be employed for more
realistic estimates of both sensitivity and specificity.
A sensitive diagnostic tool that can also distinguish be-
tween past and present infections will be most useful for
monitoring and evaluating control programmes with the
ultimate goal of elimination [9]. Antibody-detection tests
are often criticised for lacking this ability. The failure of
antibody levels to decline rapidly after treatment may
however be due in part to sub-curative effects of prazi-
quantel treatment with remaining residual infections
after treatment causing persistence of anti-schistosome
antibodies [59]. In some treated subjects antibody levels
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body levels may therefore be indicative of true parasito-
logical cure [60]. Future studies should be focussed
towards assessing the diagnostic accuracy of the RDT at
the post-treatment stage.
Conclusions
This study demonstrates that the SmCTF-RDT could be a
useful tool for mapping anti-schistosome antibody preva-
lence prior to implementation of MDA campaigns. It is as
sensitive as traditional parasitological methods, and as
specific as other routine antibody-detection methods for
the diagnosis of both S. haematobium and S. mansoni in-
fections in preschool-aged and school-aged children of
Zimbabwe.
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